Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/AGIO/vs peers

AGIOvs its industry peers

A metric-by-metric comparison of AGIO against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
CompanyMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
AGIOThis$1.9B#9—1.8x#334.5x#648.0%#4-161.3%#11-873.9%#7-40.3%#6————
ZYMEZymeworks Inc.$2.1B#1—26.6x#1020.2x#538.9%#633.9%#2-87.3%#5-100.9%#8——59.5%#3—
SEPNSepterna, Inc.$2.0B#2—5.3x#544.4x#74174.5%#131.9%#3-148.6%#6-12.6%#3——118.1%#2—
TRVITrevi Therapeutics, Inc.$2.0B#3—6.1x#6——10.7%#5—-13.3%#4——29.6%#4—
SRPTSarepta Therapeutics, Inc.$2.0B#4—1.3x#11.1x#14.3%#9-403.3%#12-37.5%#3-46.7%#7-73.0%#3—-24.2%#9—
BRVE$1.9B#6———————————
XERSXeris Biopharma Holdings, Inc.$1.9B#7——6.5x#443.7%#5101.0%#18.5%#1—20.6%#1—4.6%#6—
ZBIOZenas BioPharma, Inc.$1.8B#10—7.5x#7184.9x#8100.0%#3-140.6%#9-3830.6%#9-152.9%#10-296.6%#5—-9.2%#7—
PGENPRECIGEN, INC.$1.9B#8—43.1x#11194.1x#9146.7%#2-98.6%#8-1141.1%#8-575.1%#11-91.2%#4—26.4%#5—
GENBGenerate Biomedicines, Inc.$1.8B#12—3.9x#4————0.0%#1————
SLSSELLAS Life Sciences Group, Inc.$1.8B#11—13.0x#9—-100.0%#1013.0%#4—-19.5%#5——392.8%#1—
SUPNSUPERNUS PHARMACEUTICALS, INC.$1.6B#13—1.5x#22.3x#28.6%#8-152.2%#10-8.7%#2-3.6%#2-4.8%#2—-9.7%#8—
RARE$1.6B#14——2.4x#320.2%#7-1.1%#6-79.5%#4———-50.3%#10—
TRAX$1.9B#5—12.9x#8——-1.5%#7—-110.0%#9————

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

AGIO's peers

ZYMESEPNTRVISRPTBRVEXERSZBIOPGENGENBSLSSUPNRARETRAX
← AGIO overview